Black
cohosh continues to be increasingly popular and is the most widely-used natural
alternative to hormone replacement therapy (HRT). The herb’s popularity
with menopausal/periomenopausal women and gynecologists grew significantly
after the summer of 2003 when a large-scale government-sponsored clinical trial
on HRT was halted prematurely after evidence that HRT was responsible for an
increase in cancer and cardiovascular disease in menopausal women.
Flaxseed (Linum usitatissimum) is also an alternative to HRT and it has
gained popularity. Flaxseed is the richest known source of lignans, one of the
three major classes of phytoestrogens, and is also a rich source of
alpha-linolenic acid (ALA) and soluble and insoluble fibers. Clinical studies
are needed to measure its effectiveness.
However, an extract of black
cohosh has been used in German clinical practice since the mid-1950s with safe
and effective results, and black cohosh preparations have been approved by the
German government as nonprescription medications for treatment of menopausal
symptoms.
Remifemin is the world’s leading black cohosh product.
It has been shown effective in numerous clinical trials concluding that
Remifemin was effective in relieving menopausal symptoms.
A particular
controlled trial on 304 menopausal women demonstrated that 40 mg of the German
black cohosh preparation produced clinically significant benefits, especially
in women in their early stages of menopause, with no significant adverse side
effects.
“The evidence supporting the benefits and relative safety
of this traditional herb is becoming increasingly clear... Most of the clinical
trials published to date on black cohosh have demonstrated positive results in
helping to treat various symptoms of menopause,” said Mark Blumenthal,
founder and executive director of the American Botanical Council.
Menopausal symptoms include hot flashes (or flushes), as well as night
sweats, vaginal dryness, and mood swings.
Gail Mahady, PhD, Assistant
Professor of Pharmacy Practice at the University of Illinois at Chicago, has
reviewed most of the research on black cohosh for the World Health
Organization. She states that at least 14 clinical trials on black cohosh
preparations support their safety and efficacy in treating menopause-related
symptoms.
Most of the published clinical trials are based on the two
leading black cohosh products: Remifemin® (an extract produced by the
German company Schaper and Brümmer, and imported into the U.S. by
GlaxoSmithKline) and Klimadynon® (an extract produced by the German company
Bionorica and imported by Bionorica USA).
Black cohosh (Actaea racemosa
and Cimicifuga racemosa) is a member of the buttercup family (Ranunculaceae)
native to the Eastern United States. The roots and rhizomes (lateral roots) of
the herb have a long history of use by women in the native American tribes.
More information on
Black
Cohosh
Index of
Herbs for Health
Index of
Herbs
